← Leaderboards
Charles W Roberts
St. Jude Children'S Research Hospital
$21,463,141
Attributed
$21,670,897
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $9.8M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$95,228,798 · 8
By mechanism
P30$81,046,772 · 3
R01$13,121,807 · 3
K08$644,706 · 1
K12$415,513 · 1
Top collaborators
- Elizabeth Fox2 shared
Most similar at St. Jude Children'S Research Hospital
Same institution · by research overlap
- Richard James Gilbertson$38,555,720
- Arthur W. Nienhuis$5,923,134
- Melvin Edward Thomas$154,811
- Jordan A. Cockfield$152,324
- William E. Evans$20,051,064
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsFundingProgramsMalignant Childhood NeoplasmSaint Jude Children&AposS Research HospitalComprehensive Cancer CenterCancer CenterTranslatingGenesMemberMissionDesignResearch PersonnelClinical TrialsLaboratory ResearchCancer Center Support GrantChildMutationInnovationTumor Suppressor ProteinsComplexCellsFamily
Grant awards (89)
Cancer Center Support Grant (CCSG)$6,642,609
P30 · FY2025 · CA · contact PI
Developmental Funds$1,034,770
P30 · FY2025 · CA · contact PI
Role of the SWI/SNF complex in tumor suppression$450,446
R01 · FY2025 · CA · contact PI
The function of Snf5 (SMARCB1), an epigenetic tumor suppressor$423,510
R01 · FY2025 · CA · contact PI
Cancer-based discovery of novel mechanisms of chromatin control$416,325
R01 · FY2025 · CA · contact PI
Pediatric Oncology Career Development Program at St. Jude$381,009
K12 · FY2025 · CA · contact PI
Leadership, Planning and Evaluation$318,851
P30 · FY2025 · CA · contact PI
Cancer Center Support Grant (CCSG)$60,000
P30 · FY2025 · CA · contact PI
Cancer Center Support Grant (CCSG)$6,642,609
P30 · FY2024 · CA · contact PI
Role of the SWI/SNF complex in tumor suppression$450,446
R01 · FY2024 · CA · contact PI
The function of Snf5 (SMARCB1), an epigenetic tumor suppressor$402,334
R01 · FY2024 · CA · contact PI
Cancer-based discovery of novel mechanisms of chromatin control$395,510
R01 · FY2024 · CA · contact PI
Cancer Center Support Grant (CCSG)$227,500
P30 · FY2024 · CA · contact PI
P30 Administrative Supplement for Multi-Channel Communication Campaigns for Improvements in Cancer Education and Outcomes (MICEO) in Underserved Populations$199,698
P30 · FY2024 · CA · contact PI
P30 Administrative Supplement for Assessing and Enhancing Survivorship Care$99,999
P30 · FY2024 · CA · contact PI
Cancer Center Support Grant (CCSG)$60,000
P30 · FY2024 · CA · contact PI
Pediatric Oncology Career Development Program at St. Jude$34,504
K12 · FY2024 · CA · contact PI
Cancer Center Support Grant (CCSG)$6,551,364
P30 · FY2023 · CA · contact PI
Developmental Funds$840,647
P30 · FY2023 · CA · contact PI
Enhancing Precision of Pediatric Cancer Molecular Targets by Aggregating CCDI Genomic Data to Pediatric Cancer Knowledgebase$499,173
P30 · FY2023 · CA · contact PI
The function of Snf5 (SMARCB1), an epigenetic tumor suppressor$423,510
R01 · FY2023 · CA · contact PI
Cancer-based discovery of novel mechanisms of chromatin control$416,325
R01 · FY2023 · CA · contact PI
Leadership, Planning and Evaluation$402,559
P30 · FY2023 · CA · contact PI
Cancer Center Support Grant (CCSG)$227,500
P30 · FY2023 · CA · contact PI
Development and Piloting of a Stigma Assessment Tool for Global Pediatric Cancer$212,547
P30 · FY2023 · CA · contact PI
Multi-Channel Communication for Improvements in Cancer Education and Outcomes (MICEO) in Underserved Populations$200,000
P30 · FY2023 · CA · contact PI
Cancer Center Support Grant (CCSG)$6,551,364
P30 · FY2022 · CA · contact PI
Developmental Funds$840,647
P30 · FY2022 · CA · contact PI
The function of Snf5 (SMARCB1), an epigenetic tumor suppressor$415,039
R01 · FY2022 · CA · contact PI
Leadership, Planning and Evaluation$402,559
P30 · FY2022 · CA · contact PI
Role of the SWI/SNF complex in tumor suppression$390,919
R01 · FY2022 · CA · contact PI
Cancer Center Support Grant (CCSG)$227,500
P30 · FY2022 · CA · contact PI
Cancer Center Support Grant (CCSG)$6,394,059
P30 · FY2021 · CA · contact PI
Developmental Funds$813,016
P30 · FY2021 · CA · contact PI
The function of Snf5 (SMARCB1), an epigenetic tumor suppressor$442,391
R01 · FY2021 · CA · contact PI
Role of the SWI/SNF complex in tumor suppression$399,004
R01 · FY2021 · CA · contact PI
Leadership, Planning and Evaluation$389,326
P30 · FY2021 · CA · contact PI
The Impact of Stigma on Cancer Care Decision-Making Among Patients with Osteosarcoma and Retinoblastoma in Zimbabwe, Guatemala and Jordan$224,375
P30 · FY2021 · CA · contact PI
Cancer Center Support Grant (CCSG)$60,000
P30 · FY2021 · CA · contact PI
Cancer Center Support Grant (CCSG)$6,551,364
P30 · FY2020 · CA · contact PI
Developmental Funds$840,647
P30 · FY2020 · CA · contact PI
Cancer Center Support Grant (CCSG)$500,000
P30 · FY2020 · CA · contact PI
Leadership, Planning and Evaluation$402,559
P30 · FY2020 · CA · contact PI
Role of the SWI/SNF complex in tumor suppression$399,112
R01 · FY2020 · CA · contact PI
Cancer Center Support Grant (CCSG)$99,999
P30 · FY2020 · CA · contact PI
Cancer Center Support Grant (CCSG)$60,000
P30 · FY2020 · CA · contact PI
Cancer Center Support Grant (CCSG)$6,323,461
P30 · FY2019 · CA · contact PI
Developmental Funds$813,656
P30 · FY2019 · CA · contact PI
Leadership, Planning and Evaluation$389,634
P30 · FY2019 · CA · contact PI
Role of the SWI/SNF complex in tumor suppression$387,236
R01 · FY2019 · CA · contact PI
The function of Snf5, an epigenetic tumor suppressor$358,663
R01 · FY2019 · CA · contact PI
Cancer Center Support Grant Year 35 (CCSG)$6,063,271
P30 · FY2018 · CA · contact PI
Role of the SWI/SNF complex in tumor suppression$419,188
R01 · FY2018 · CA · contact PI
The function of Snf5, an epigenetic tumor suppressor$369,757
R01 · FY2018 · CA · contact PI
Cancer Center Support Grant Year 35 (CCSG)$134,625
P30 · FY2018 · CA · contact PI
Cancer Center Support Grant Year 35 (CCSG)$58,898
P30 · FY2018 · CA · contact PI
Cancer Center Support Grant Year 35 (CCSG)$6,063,271
P30 · FY2017 · CA · contact PI
The function of Snf5, an epigenetic tumor suppressor$369,757
R01 · FY2017 · CA · contact PI
Role of the SWI/SNF complex in tumor suppression$357,826
R01 · FY2017 · CA · contact PI
Cancer Center Support Grant Year 35 (CCSG)$174,253
P30 · FY2017 · CA · contact PI
Cancer Center Support Grant Year 35 (CCSG)$134,625
P30 · FY2017 · CA · contact PI
Cancer Center Support Grant Year 35 (CCSG)$6,046,382
P30 · FY2016 · CA · contact PI
The function of Snf5, an epigenetic tumor suppressor$369,534
R01 · FY2016 · CA · contact PI
Role of the SWI/SNF complex in tumor suppression$335,023
R01 · FY2016 · CA · contact PI
Cancer Center Support Grant Year 35 (CCSG)$134,250
P30 · FY2016 · CA · contact PI
Cancer Center Support Grant Year 35 (CCSG)$120,602
P30 · FY2016 · CA · contact PI
Cancer Center Support Grant Year 35 (CCSG)$6,012,603
P30 · FY2015 · CA · contact PI
Role of the SWI/SNF complex in tumor suppression$208,753
R01 · FY2015 · CA · contact PI
The function of Snf5, an epigenetic tumor suppressor$194,007
R01 · FY2015 · CA · contact PI
The function of Snf5, an epigenetic tumor suppressor$175,056
R01 · FY2015 · CA · contact PI
Analysis of the role of the SWI/SNF complex in tumor suppression$150,503
R01 · FY2015 · CA · contact PI
Analysis of the role of the SWI/SNF complex in tumor suppression$348,478
R01 · FY2014 · CA · contact PI
The function of Snf5, an epigenetic tumor suppressor$316,886
R01 · FY2014 · CA · contact PI
Analysis of the role of the SWI/SNF complex in tumor suppression$359,256
R01 · FY2013 · CA · contact PI
The function of Snf5, an epigenetic tumor suppressor$307,107
R01 · FY2013 · CA · contact PI
The function of Snf5, an epigenetic tumor suppressor$326,730
R01 · FY2012 · CA · contact PI
The function of Snf5, an epigenetic tumor suppressor$326,750
R01 · FY2011 · CA · contact PI
The function of Snf5, an epigenetic tumor suppressor$335,974
R01 · FY2010 · CA · contact PI
The function of Snf5, an epigenetic tumor suppressor$320,225
R01 · FY2009 · CA · contact PI
The function of Snf5, an epigenetic tumor suppressor$320,225
R01 · FY2008 · CA · contact PI
The function of Snf5, an epigenetic tumor suppressor$320,225
R01 · FY2007 · CA · contact PI
The function of Snf5, an epigenetic tumor suppressor$54,720
R01 · FY2007 · CA · contact PI
The function of Snf5, an epigenetic tumor suppressor$329,307
R01 · FY2006 · CA · contact PI
Analysis of the Novel Tumor Suppressor Gene SNF5/INI1$101,358
K08 · FY2006 · CA · contact PI
The function of Snf5, an epigenetic tumor suppressor$335,750
R01 · FY2005 · CA
Analysis of the Novel Tumor Suppressor Gene SNF5/INI1$135,837
K08 · FY2005 · CA
Analysis of the Novel Tumor Suppressor Gene SNF5/INI1$135,837
K08 · FY2004 · CA
Analysis of the Novel Tumor Suppressor Gene SNF5/INI1$135,837
K08 · FY2003 · CA
Analysis of the Novel Tumor Suppressor Gene SNF5/INI1$135,837
K08 · FY2002 · CA